MammoCoach will debut at RSNA 2014 an online teaching product for screening mammography.
MammoCoach will debut at RSNA 2014 its online teaching product that earns recipients CME and improves their screening mammography skills, the company announced.
The tool is devised to increase a readers experience to more than 1000 mammograms, MammoCoach said. MammoCoach was developed by a team of experts from academia, private practice, industry, and public health.
MammoCoach includes a cloud-based collection of 1000 screening mammograms, including two-year-old prior studies on a viewer with hanging protocols to evaluate the cases in a timely fashion. Among the cases are 100 recalls, including diagnostic work-up and a final amount of 3–5 malignancies, as well as access to a large electronic case collection to further retrain certain aspects of breast imaging, the company said. Cases can be reviewed with feedback from faculty, comparison with peers, and learning cases.
The tool also provides a feature that shows the user when other readers, including the five most experienced super readers, decided not to call the patient back based on specific criteria.
MammoCoach is self-proclaimed as “the first online teaching program focusing on coaching screening mammography skills under realistic conditions.”
[[{"type":"media","view_mode":"media_crop","fid":"29686","attributes":{"alt":"MammoCoach","class":"media-image media-image-right","id":"media_crop_2148978577820","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3087","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 153px; width: 441px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.